Dr Matt & Dr Mike's Medical Podcast

Dr Matt & Dr Mike's A-Z of the Human Body is a concise, engaging podcast series that explores human anatomy and physiology one term at a time. Hosted by Dr Matt Barton (Griffith University) and Dr Mike Todorovic (Bond University), both experienced educators and science communicators, the series aims to make complex medical concepts accessible and enjoyable.

Visit podcast website

Download MedPod Learn

Make more of your medical podcast listening. Browse and listen free in MedPod Learn; Premium adds structured notes, self-test questions, reflection and exportable learning records.
This website provides podcast information and episode previews.
Try MedPod’s learning tools with a St Emlyn’s sample
September 13, 2026

ADHD Made Easy w/ Dr Kieran Kennedy

Adult ADHD may remain hidden behind academic success, detailed routines and suppressed restlessness, while dysregulated attention, anxiety and exhaustion persist; assessment should explore childhood symptoms and functional impact, with treatment tailored across practical strategies, psychological support and individually reviewed medication.

September 6, 2026

Protein Synthesis Inhibitors | Antibiotics (4 of 4)

Aminoglycosides, tetracyclines, macrolides and chloramphenicol inhibit bacterial protein synthesis at the 30S or 50S ribosomal subunits, but differ in mechanism, antimicrobial activity, toxicity, interactions and the monitoring required during clinical use.

August 30, 2026

Atoms & Bonds (Covalent, Ionic, and Hydrogen)

Outer-shell electrons explain how covalent, ionic and hydrogen bonds form in biological molecules. Water polarity then connects basic chemistry with electrolyte dissolution, osmosis, membrane electrical activity, fat solubility and reversible DNA strand pairing.

August 23, 2026

Our Top 3 Organs!

Foot drop localisation, hyperacusis in facial palsy and pain around the pectinate line turn anatomy into clinical decisions. The wider review also links renal filtration, intrinsic cardiac rhythm and neuronal energy use to organ homeostasis.

August 16, 2026

Chronic Kidney Disease

Preserved eGFR does not exclude chronic kidney disease when albuminuria or another structural marker persists for at least three months. The discussion links nephron workload, hyperfiltration, cardiovascular risk and treatment aimed at protecting remaining kidney function.

August 9, 2026

Q&A#15 | Vitamins, Glucose Transporters, Water Balance, and Respiratory Failure

Vitamins act as micronutrients and coenzyme precursors, while glucose transporter proteins explain how glucose crosses cell membranes and how exercise can increase skeletal-muscle uptake independently of insulin. The same physiology links antidiuretic hormone and aldosterone to volume defence and separates oxygen-transfer failure from inadequate ventilation.

August 2, 2026

Autonomic Pharmacology

Emergency, respiratory, toxicology and pharmacology learners get a mechanism-first review of the autonomic nervous system. Adrenergic and muscarinic receptors are linked to clinically familiar drugs including salbutamol, beta blockers, clonidine, atropine, ipratropium, tiotropium, neostigmine and donepezil.

July 19, 2026

Paramedics Toolkit | Part 2 of 2

Prehospital, emergency and critical-care clinicians get a mechanism-led review of medicines used for analgesia, sedation, seizure control, bradycardia, bronchospasm, shock, haemorrhage and acute coronary syndromes. Receptor and pathway effects are connected to physiological targets, adverse effects, protocol restrictions and structured medication handover.

July 12, 2026

Paramedics Toolkit | Part 1 of 2

Prehospital, emergency and toxicology clinicians get a mechanism-led tour of the paramedic drug kit. Adrenaline, antiplatelets, anticoagulants, blood products, calcium, insulin, bronchodilators and antidotes are linked to indications, physiological targets, safety checks and structured handover.

July 5, 2026

DNA Inhibitors | Antibiotics

Infectious-diseases, primary-care and basic-science learners get a mechanism-led review of DNA-inhibiting antibiotics. Metronidazole, rifamycins and fluoroquinolones are separated by target, infection site and safety profile, with anaerobic infection, protozoal disease, tuberculosis, urinary infection, respiratory infection, resistance risk, interactions and counselling kept in view.